Skip to main content
SpringerLink
Log in

Glutathione deficiency in patients with mitochondrial disease: Implications for pathogenesis and treatment

  • Published:
Journal of Inherited Metabolic Disease

Summary

Glutathione (GSH) is a key intracellular antioxidant. With regard to mitochondrial function, loss of GSH is associated with impairment of the electron transport chain (ETC). Since GSH biosynthesis is an energy-dependent process, we postulated that in patients with ETC defects GSH status becomes compromised, leading to further loss of ETC activity. We performed electrochemical HPLC analysis to determine the GSH concentration of 24 skeletal muscle biopsies from patients with defined ETC defects compared to 15 age-matched disease controls. Comparison of these groups revealed a significant (p <0.001) decrease in GSH concentration in the ETC-deficient group: 7.7 ± 0.9 vs 12.3 ± 0.6 nmol/mg protein in the control group. Further analysis of the data revealed that patients with multiple defects of the ETC had the most marked GSH deficiency: 4.1 ± 0.9 nmol/mg protein (n = 4, p < 0.05) when compared to the control group. These findings suggest that a deficiency in skeletal muscle GSH concentration is associated with an ETC defect, possibly as a consequence of diminished ATP availability or increased oxidative stress. The decreased ability to combat oxidative stress could therefore cause further loss of ETC activity and hence be a contributing factor in the progressive nature of this group of disorders. Furthermore, restoration of cellular GSH status could prove to be of therapeutic benefit in patients with a GSH deficiency associated with their ETC defects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson MF, Nilsson M, Eriksson PS, et al (2004) Glutathione monoethyl ester provides neuroprotection in a rat model of stroke. Neurosci Lett 354: 163–165.

    Article  PubMed  CAS  Google Scholar 

  • Bolanos JP, Heales SJR, Peuchen S, et al (1996) Nitric oxide mediated mitochondrial damage. Free Radic Biol 21: 995–1001.

    Article  CAS  Google Scholar 

  • Chen Q, Vazquez EJ, Moghaddas S, et al (2003) Production of reactive oxygen species by mitochondria. J Biol Chem 278: 36027–36031.

    PubMed  CAS  Google Scholar 

  • Dimonte DA, Chan P, Sandy MS (1992) Glutathione in Parkinson’s disease: a link between oxidative stress and mitochondrial damage? Ann Neurol 32: S111–115.

    CAS  Google Scholar 

  • Grant CM, Maciver FH, Dawes IW (1997) Glutathione synthetase is dispensable for growth under both normal and oxidative stress conditions in the yeast Saccharomyces cerevisiae due to an accumulation of the dipeptide gamma-glutamylcysteine. Mol Biol Cell 8: 1699–1707.

    PubMed  CAS  Google Scholar 

  • Heales SJ, Bolanos JP (2002) Impairment of mitochondrial function by reactive oxygen nitrogen species: the role of glutathione in dictating susceptibility. Neurochem Int 40: 469–474.

    Article  PubMed  CAS  Google Scholar 

  • Heales SJR, Davies SEC, Bates TE, et al (1995) Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 20: 31–38.

    Article  PubMed  CAS  Google Scholar 

  • Heales SJR, Bolanos JP, Brand M, et al (1996a) Mitochondrial damage: an important feature in a number of inborn errors of metabolism. J Inherit Metab Dis 19: 140–142.

    Article  PubMed  CAS  Google Scholar 

  • Heales SJR, Hargreaves IP, Olpin SE, et al (1996b) Diagnosis of mitochondrial electron transport chain defects in small muscle biopsies. J Inherit Metab Dis 19(Supplement 1): P151.

    Google Scholar 

  • Hetherington HP, Spencer DD, Vaughan JT, et al (2001) Quantitative 31P spectroscopic imaging of human brain at 4T: assessment of gray and white matter differences of phosphocreatine and ATP. Magn Reson Med 45: 46–52.

    Article  PubMed  CAS  Google Scholar 

  • Jha N, Jurma O, Lalli G, et al (2000) Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. J Biol Chem 275: 26096–26101.

    Article  PubMed  CAS  Google Scholar 

  • Kang D, Hamasaki N (2003) Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med 41: 1281–1288.

    Article  PubMed  CAS  Google Scholar 

  • Kowaltowski AJ, Vercesi AE (1999) Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 26: 463–471.

    Article  PubMed  CAS  Google Scholar 

  • Laganiere S, Yu BP (1993) Modulation of membrane phospholipid fatty acid composition and food restriction. Gerontology 39: 7–18.

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.

    PubMed  CAS  Google Scholar 

  • Martensson J, Lai JCK, Meister A (1990) High affinity transport of glutathione is part of a multicomponent system essential for mitochondrial function. Proc Natl Acad Sci USA 87: 7185–7189.

    PubMed  CAS  Google Scholar 

  • Merad-Saidoune M, Boitier E, Nicole A, et al (1999) Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents brain mitochondrial respiratory chain dysfunction induced by glutathione depletion. Exp Neurol 158: 428–436.

    PubMed  CAS  Google Scholar 

  • Njalsson R, Norgren S, Larsson A, et al (2001) Cooperative binding of γ-gluamyl substrate to human glutathione synthetase. Biochem Biophys Res Commun 289: 80–84.

    Article  PubMed  CAS  Google Scholar 

  • Okubo T, Yomoyama Y, Kano K, et al (2004) Molecular mechanism of cell death induced by the antioxidant tert-butylhydroxyanisole in human monocytic leukemia U937 cells. Biol Pharm Bull 27: 295–302.

    Article  PubMed  CAS  Google Scholar 

  • Paradies G, Ruggiero FM, Petrosillo G, et al (1998) Peroxidative damage to cardiac mitochondria: cytochrome c oxidase and cardiolipin alterations. FEBS Lett 424: 155–158.

    Article  PubMed  CAS  Google Scholar 

  • Pedersen PL (1994) ATP synthase. The machine that makes ATP. Curr Biol 4: 1138–1141.

    Article  PubMed  CAS  Google Scholar 

  • Riederer P, Sofic E, Rausch W-D, et al (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem 52: 512–520.

    Google Scholar 

  • Ristoff E, Larsson A (2002) Oxidative stress in inborn errors of metabolism: lessons from glutathione deficiency. J Inherit Metab Dis 25: 223–226.

    PubMed  CAS  Google Scholar 

  • Ristoff E, Hebert C, Njalsson R, et al (2002) Glutathione synthetase deficiency: Is γ-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione. J Inherit Metab Dis 25: 577–584.

    PubMed  CAS  Google Scholar 

  • Rossignol R, Letellier T, Malgat M, et al (2000) Tissue variation in the control of oxidative phosphorylation: implications for mitochondrial diseases. Biochem J 347: 45–53.

    Article  PubMed  CAS  Google Scholar 

  • Schapira AHV, Cooper JM, Dexter D, et al (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54: 823–827.

    PubMed  CAS  Google Scholar 

  • Seelig GF, Meister A (1984) γ-Glutamylcysteine synthetase. Interactions of an essential sulfhydryl group. J Biol Chem 6: 3534–3538.

    Google Scholar 

  • Sian J, Dexter DT, Lees AJ, et al (1994) Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative diseases affecting basal ganglia. Ann Neurol 36: 348–355.

    PubMed  CAS  Google Scholar 

  • St-Pierre J, Buckingham JA, Roebuck SJ, et al (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277: 44784–44790.

    PubMed  CAS  Google Scholar 

  • Wallace DC, Brown MD, Melov S, et al (1998) Mitochondrial biology, degenerative diseases and aging. Biofactors 7: 187–190.

    PubMed  CAS  Google Scholar 

  • Wu G, Fang YZ, Yang S, et al (2004) Glutathione metabolism and its implications for health. J Nutr 134: 489–492.

    PubMed  CAS  Google Scholar 

  • Zhang Y, Marcillat O, Giulivi C, et al (1990) The oxidative inactivation of mitochondrial electron transport components and ATPase. J Biol Chem 265: 16330–16336.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, WC1N 3BG, London, UK

    I. P. Hargreaves, Y. Sheena, J. M. Land & S. J. R. Heales

Authors
  1. I. P. Hargreaves
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Sheena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. M. Land
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. J. R. Heales
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. P. Hargreaves.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hargreaves, I.P., Sheena, Y., Land, J.M. et al. Glutathione deficiency in patients with mitochondrial disease: Implications for pathogenesis and treatment. J Inherit Metab Dis 28, 81–88 (2005). https://doi.org/10.1007/s10545-005-4160-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-005-4160-1

Keywords

Search

Navigation